Evidence map›Paper›PMID 18452050›Full record

Trial reportObesity surgery2009

Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance.

Georg Schaller, Yoshimasa Aso, Gerit-Holger Schernthaner, Hans-Peter Kopp, Toshihiko Inukai, Stefan Kriwanek, Guntram Schernthaner

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Obesity surgery, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Inflammatory markers and bariatric surgery: a meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2012
    Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Georg SchallerDepartment of Internal Medicine I, Rudolfstiftung Hospital, Juchgasse 25, 1030, and Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria. georg.schaller@wienkav.at
Yoshimasa Aso
Gerit-Holger Schernthaner
Hans-Peter Kopp
Toshihiko Inukai
Stefan Kriwanek
Guntram Schernthaner
Dokkyo Medical University Saitama Medical Center · JPMedical University of Vienna · ATRudolfinerhaus Hospital · ATKrankenanstalt Rudolfstiftung der Stadt Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteopontin (OPN) is a multifunctional matrix glycoprotein associated with bone metabolism and has been linked to chronic inflammation, insulin resistance, and atherosclerosis. Diet-induced weight loss decreases elevated OPN concentrations in obese patients. The aim of the current study was to investigate the role of OPN after bariatric surgery, where not only improvements of chronic inflammation, insulin resistance and comorbidities, but also malabsorption and altered bone metabolism have been reported.

methodsOPN plasma concentrations were determined in 31 morbidly obese patients (5 men, 26 women, BMI 46.2+/-7.1 kg/m2, age 41+/-11 years; mean+/-SD) before and 18 months after bariatric surgery, together with parameters of bone metabolism and inflammation.

resultsOPN concentrations increased by +20.3+/-26.6 ng/ml (mean+/-SD, p<0.01), concomitant to a weight loss of -38+/-22 kg, and a decrease in BMI by -13.1+/-7.7 kg/m2 (both p<0.01). HOMA-index improved from 5.2+/-3.4 to 1.5+/-1.0 (p<0.01). Calcium concentrations slightly decreased, and phosphate increased (-0.06+/-0.13 mmol/l and +0.08+/-0.16 mmol/l, respectively; both p<0.05), while 25-OH-Vitamin D3 remained unchanged and PTH tended to increase (+5.1+/-14.0 pg/ml, p=0.054). Monocyte chemoattractant protein 1 and interleukin 18 were significantly decreased and associated with HOMA both before and after bariatric surgery. DeltaOPN was correlated with DeltaPTH, but not with other parameters.

conclusionsOPN plasma concentrations increased concomitant to weight loss after bariatric surgery, which was independent from an improvement of insulin sensitivity and a decrease of inflammatory markers. Further studies are needed to differentiate whether these changes in bone metabolism after bariatric surgery are secondary to calcium deficiency or an adaptation to weight loss.

Indexed as

AdultBody Mass IndexBone RemodelingChemokine CCL2Cohort StudiesC-Reactive ProteinFemaleHumansInsulin ResistanceInterleukin-18MaleMiddle AgedObesity, MorbidOsteopontinTreatment OutcomeWeight LossCCL2 protein, humanChemokine CCL2C-Reactive ProteinInterleukin-18Osteopontin

Identifiers

PMID18452050
OpenAlexW2031119497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.